Lindbrook Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $29.2K | Sell |
938
-509
| -35% | -$15.8K | ﹤0.01% | 1197 |
|
|
2024
Q4 | $36.9K | Buy |
1,447
+316
| +28% | +$8.06K | ﹤0.01% | 948 |
|
|
2024
Q3 | $32K | Sell |
1,131
-697
| -38% | -$19.7K | ﹤0.01% | 1030 |
|
|
2024
Q2 | $48.2K | Sell |
1,828
-572
| -24% | -$15.1K | ﹤0.01% | 809 |
|
|
2024
Q1 | $72.9K | Sell |
2,400
-11
| -0.5% | -$334 | 0.01% | 645 |
|
|
2023
Q4 | $67.7K | Buy |
2,411
+1,999
| +485% | +$56.2K | 0.01% | 655 |
|
|
2023
Q3 | $11.2K | Buy |
412
+136
| +49% | +$3.69K | ﹤0.01% | 1354 |
|
|
2023
Q2 | $8.48K | Sell |
276
-198
| -42% | -$6.09K | ﹤0.01% | 1568 |
|
|
2023
Q1 | $17.1K | Buy |
474
+451
| +1,961% | +$16.2K | ﹤0.01% | 1149 |
|
|
2022
Q4 | $909 | Buy |
23
+13
| +130% | +$514 | ﹤0.01% | 2483 |
|
|
2022
Q3 | $0 | Sell |
10
-169
| -94% | – | ﹤0.01% | 2888 |
|
|
2022
Q2 | $8K | Buy |
179
+154
| +616% | +$6.88K | ﹤0.01% | 1361 |
|
|
2022
Q1 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 2341 |
|